These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36599698)

  • 1. Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury.
    Stukas S; Cooper J; Gill J; Fallah N; Skinnider MA; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Bailey CS; Dhall S; Mac-Thiong JM; Wilson JR; Christie S; Dvorak MF; Wellington CL; Kwon BK
    Neurology; 2023 Mar; 100(12):e1221-e1233. PubMed ID: 36599698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Biomarkers To Stratify Injury Severity and Predict Outcome in Human Traumatic Spinal Cord Injury.
    Kwon BK; Streijger F; Fallah N; Noonan VK; Bélanger LM; Ritchie L; Paquette SJ; Ailon T; Boyd MC; Street J; Fisher CG; Dvorak MF
    J Neurotrauma; 2017 Feb; 34(3):567-580. PubMed ID: 27349274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.
    Pouw MH; Kwon BK; Verbeek MM; Vos PE; van Kampen A; Fisher CG; Street J; Paquette SJ; Dvorak MF; Boyd MC; Hosman AJ; van de Meent H
    Spinal Cord; 2014 Jun; 52(6):428-33. PubMed ID: 24710150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers.
    Dalkilic T; Fallah N; Noonan VK; Salimi Elizei S; Dong K; Belanger L; Ritchie L; Tsang A; Bourassa-Moreau E; Heran MKS; Paquette SJ; Ailon T; Dea N; Street J; Fisher CG; Dvorak MF; Kwon BK
    J Neurotrauma; 2018 Feb; 35(3):435-445. PubMed ID: 29037121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectory of Serum Levels of Glial Fibrillary Acidic Protein Within Four Weeks Post-Injury Is Related to Neurological Recovery During the Transition from Acute to Chronic Spinal Cord Injury.
    Leister I; Altendorfer B; Maier D; Mach O; Wutte C; Grillhösl A; Arevalo-Martin A; Garcia-Ovejero D; Aigner L; Grassner L
    J Neurotrauma; 2023 May; 40(9-10):999-1006. PubMed ID: 36200629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study.
    Wichmann TO; Kasch H; Dyrskog S; Høy K; Møller BK; Krog J; Hoffmann HJ; Hviid CVB; Rasmussen MM
    Acta Neurochir (Wien); 2023 Jun; 165(6):1417-1425. PubMed ID: 36790588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein Are Related to the Neurological Impairment and Spinal Edema after Traumatic Spinal Cord Injury.
    Leister I; Altendorfer B; Maier D; Mach O; Wutte C; Grillhösl A; Arevalo-Martin A; Garcia-Ovejero D; Aigner L; Grassner L
    J Neurotrauma; 2021 Dec; 38(24):3431-3439. PubMed ID: 34541888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
    Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury.
    Stukas S; Gill J; Cooper J; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Dhall S; Mac-Thiong JM; Wilson JR; Bailey C; Christie S; Dvorak MF; Wellington C; Kwon BK
    J Neurotrauma; 2021 Aug; 38(15):2055-2064. PubMed ID: 33504255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
    Kwon BK; Stammers AM; Belanger LM; Bernardo A; Chan D; Bishop CM; Slobogean GP; Zhang H; Umedaly H; Giffin M; Street J; Boyd MC; Paquette SJ; Fisher CG; Dvorak MF
    J Neurotrauma; 2010 Apr; 27(4):669-82. PubMed ID: 20038240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Cerebrospinal Fluid and Serum Biomarker Levels and Diagnosis, Injury Severity, and Short-Term Outcomes in Patients with Acute Traumatic Spinal Cord Injury.
    Yang Z; Apiliogullari S; Fu Y; Istanbouli A; Kaur S; Jabbal IS; Moghieb A; Irfan Z; Patterson RL; Kurup M; Morrow L; Cohn M; Zhang Z; Zhu J; Hayes RL; Bramlett HM; Bullock MR; Dietrich WD; Wang MY; Kobeissy F; Wang KW
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion.
    Olby NJ; Lim JH; Wagner N; Zidan N; Early PJ; Mariani CL; Muñana KR; Laber E
    J Vet Intern Med; 2019 Mar; 33(2):726-734. PubMed ID: 30758078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury.
    Tigchelaar S; Gupta R; Shannon CP; Streijger F; Sinha S; Flibotte S; Rizzuto MA; Street J; Paquette S; Ailon T; Charest-Morin R; Dea N; Fisher C; Dvorak MF; Dhall S; Mac-Thiong JM; Parent S; Bailey C; Christie S; Van Keuren-Jensen K; Nislow C; Kwon BK
    J Neurotrauma; 2019 Aug; 36(15):2358-2371. PubMed ID: 30827169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury.
    Streijger F; Skinnider MA; Rogalski JC; Balshaw R; Shannon CP; Prudova A; Belanger L; Ritchie L; Tsang A; Christie S; Parent S; Mac-Thiong JM; Bailey C; Urquhart J; Ailon T; Paquette S; Boyd M; Street J; Fisher CG; Dvorak MF; Borchers CH; Foster LJ; Kwon BK
    J Neurotrauma; 2017 Jun; 34(12):2054-2068. PubMed ID: 28276985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Ubiquitin C-Terminal Hydrolase-L1, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain Are Good Entry Points and Biomarker Candidates for Neurosyphilis Diagnosis Among Patients Without Human Immunodeficiency Virus to Avoid Lumbar Puncture.
    Xie L; Li W; Ye WM; Xiao Y; Ke WJ; Niu JJ; Yang TC
    Clin Infect Dis; 2023 Aug; 77(3):472-479. PubMed ID: 36929815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration.
    Holmström U; Tsitsopoulos PP; Holtz A; Salci K; Shaw G; Mondello S; Marklund N
    Acta Neurochir (Wien); 2020 Sep; 162(9):2075-2086. PubMed ID: 32588294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury.
    Hossain I; Mohammadian M; Takala RSK; Tenovuo O; Lagerstedt L; Ala-Seppälä H; Frantzén J; van Gils M; Hutchinson P; Katila AJ; Maanpää HR; Menon DK; Newcombe VF; Tallus J; Hrusovsky K; Wilson DH; Blennow K; Sanchez JC; Zetterberg H; Posti JP
    J Neurotrauma; 2019 May; 36(10):1551-1560. PubMed ID: 30489229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury.
    Korley FK; Nikolian VC; Williams AM; Dennahy IS; Weykamp M; Alam HB
    J Neurotrauma; 2018 May; 35(10):1185-1191. PubMed ID: 29415612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study.
    Hayakawa K; Okazaki R; Ishii K; Ueno T; Izawa N; Tanaka Y; Toyooka S; Matsuoka N; Morioka K; Ohori Y; Nakamura K; Akai M; Tobimatsu Y; Hamabe Y; Ogata T
    Spinal Cord; 2012 Jul; 50(7):493-6. PubMed ID: 22270191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.